Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks seen lower after hitting record high
(Sharecast News) - London stocks were set to fall at the open on Monday, after the top-flight index hit a record high at the end of last week. The FTSE 100 was called to open 25 points lower at 7,876.
CMC Markets analyst Michael Hewson said: "As we look ahead the beginning of a new week, rates markets have continued to see yields push higher and that looks set to see a weaker European open, even as the Japanese yen slips back sharply in Asia on reports that Bank of Japan governor Kuroda's successor might be his deputy Amamiya, raising the prospect of continuity when it comes to easy monetary policy.
"The sharp slide in the value of the pound is also likely to be a worry for the Bank of England with inflation still well into double figures. External MPC member Catherine Mann is due to speak later today, as is Chief economist Huw Pill, and their comments could offer food for thought in respect of where they see the terminal rate for UK rates, with the current base rate at 4%."
In corporate news, chemicals company Croda has agreed to acquire biomaterials firm Solus Biotech for KRW 350.0bn (£232.0m) one a cash and debt-free basis.
Croda said the acquisition provides it with access to Solus' existing biotech-derived ceramide and phospholipid technologies, and will "significantly strengthen" its beauty actives portfolio and increase its exposure to targeted "prestige segments".
Molten metal flow engineering and technology firm Vesuvius said it had been hit by a cyber attack involving "unauthorised access" to its systems.
"Immediately upon becoming aware of unauthorised activity on our networks, we have taken the necessary steps to investigate and respond to the incident, including shutting down affected systems," the company said.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.